Matches in SemOpenAlex for { <https://semopenalex.org/work/W2114748064> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W2114748064 endingPage "9" @default.
- W2114748064 startingPage "774" @default.
- W2114748064 abstract "A spontaneously metastasizing solid tumor model derived by transplanting the TA3Ha murine mammary carcinoma into the s.c. tail tissue of mice was used to develop a treatment strategy for enhancing the therapeutic efficacy of cisplatin (CDDP). This strategy was based on the findings that diethyldithiocarbamate (DDTC) reduces the toxicity of CDDP, and that localized hyperthermia (HT) augments the antitumor efficacy of CDDP. DDTC (500 mg/kg) reduced the CDDP-induced nephrotoxicity and gastrointestinal toxicity as well as increased the CDDP LD10 from 8 to 20 mg/kg in strain A mice. When CDDP and DDTC were used in multiple treatment schedules at 5-day intervals, DDTC protected the hosts but not the tumors against the toxicity of CDDP. HT administered locally to the tumor 1 h after the injection of CDDP (8 mg/kg) in 1 ml Hanks' balanced salt solution increased the antitumor effect but not the host toxicity. While administration of 8 mg/kg CDDP alone or with HT three times at 5-day intervals caused 100% host mortality, this dose of CDDP could be used with no mortality by combining it with DDTC. A combination of 8 mg/kg CDDP with DDTC (750 mg/kg) and HT (43 degree C for 60 min), administered three times at 5-day intervals, retarded the local tumor growth significantly compared to the untreated, CDDP plus DDTC plus HT control groups of mice. The frequency of lung metastasis in these groups on day 30 of tumor inoculation were 0, 90, 90, and 80%, respectively. The mean survival days of the mice treated with CDDP plus DDTC plus HT was 61 +/- 6 compared to 34 +/- 5 in the controls. The results presented here demonstrate that by combining CDDP with DDTC, high doses of CDDP can be safely administered. When localized HT is combined with high dose CDDP and DDTC, the tumor growth retardation and the host survival prolongation are significantly better than those obtained with the highest tolerable dose of CDDP alone or CDDP plus HT." @default.
- W2114748064 created "2016-06-24" @default.
- W2114748064 creator A5001891207 @default.
- W2114748064 creator A5008058560 @default.
- W2114748064 creator A5068737034 @default.
- W2114748064 creator A5084528874 @default.
- W2114748064 date "1987-02-01" @default.
- W2114748064 modified "2023-09-26" @default.
- W2114748064 title "Enhanced therapeutic efficacy of cisplatin by combination with diethyldithiocarbamate and hyperthermia in a mouse model." @default.
- W2114748064 cites W1501723034 @default.
- W2114748064 cites W1534154744 @default.
- W2114748064 cites W1552701243 @default.
- W2114748064 cites W1588328820 @default.
- W2114748064 cites W1593858516 @default.
- W2114748064 cites W1770665526 @default.
- W2114748064 cites W1833724858 @default.
- W2114748064 cites W1967094642 @default.
- W2114748064 cites W2124242608 @default.
- W2114748064 cites W2146014869 @default.
- W2114748064 cites W2232433897 @default.
- W2114748064 cites W2344682853 @default.
- W2114748064 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/3026616" @default.
- W2114748064 hasPublicationYear "1987" @default.
- W2114748064 type Work @default.
- W2114748064 sameAs 2114748064 @default.
- W2114748064 citedByCount "10" @default.
- W2114748064 crossrefType "journal-article" @default.
- W2114748064 hasAuthorship W2114748064A5001891207 @default.
- W2114748064 hasAuthorship W2114748064A5008058560 @default.
- W2114748064 hasAuthorship W2114748064A5068737034 @default.
- W2114748064 hasAuthorship W2114748064A5084528874 @default.
- W2114748064 hasConcept C121608353 @default.
- W2114748064 hasConcept C126189478 @default.
- W2114748064 hasConcept C126322002 @default.
- W2114748064 hasConcept C185592680 @default.
- W2114748064 hasConcept C19831878 @default.
- W2114748064 hasConcept C2776694085 @default.
- W2114748064 hasConcept C2778239845 @default.
- W2114748064 hasConcept C2779013556 @default.
- W2114748064 hasConcept C2779949491 @default.
- W2114748064 hasConcept C2780035454 @default.
- W2114748064 hasConcept C29730261 @default.
- W2114748064 hasConcept C71924100 @default.
- W2114748064 hasConcept C98274493 @default.
- W2114748064 hasConceptScore W2114748064C121608353 @default.
- W2114748064 hasConceptScore W2114748064C126189478 @default.
- W2114748064 hasConceptScore W2114748064C126322002 @default.
- W2114748064 hasConceptScore W2114748064C185592680 @default.
- W2114748064 hasConceptScore W2114748064C19831878 @default.
- W2114748064 hasConceptScore W2114748064C2776694085 @default.
- W2114748064 hasConceptScore W2114748064C2778239845 @default.
- W2114748064 hasConceptScore W2114748064C2779013556 @default.
- W2114748064 hasConceptScore W2114748064C2779949491 @default.
- W2114748064 hasConceptScore W2114748064C2780035454 @default.
- W2114748064 hasConceptScore W2114748064C29730261 @default.
- W2114748064 hasConceptScore W2114748064C71924100 @default.
- W2114748064 hasConceptScore W2114748064C98274493 @default.
- W2114748064 hasIssue "3" @default.
- W2114748064 hasLocation W21147480641 @default.
- W2114748064 hasOpenAccess W2114748064 @default.
- W2114748064 hasPrimaryLocation W21147480641 @default.
- W2114748064 hasRelatedWork W1994716500 @default.
- W2114748064 hasRelatedWork W1994790143 @default.
- W2114748064 hasRelatedWork W2072488592 @default.
- W2114748064 hasRelatedWork W2085185859 @default.
- W2114748064 hasRelatedWork W2114748064 @default.
- W2114748064 hasRelatedWork W2351312879 @default.
- W2114748064 hasRelatedWork W2410103609 @default.
- W2114748064 hasRelatedWork W2418638035 @default.
- W2114748064 hasRelatedWork W2767770044 @default.
- W2114748064 hasRelatedWork W2995316848 @default.
- W2114748064 hasVolume "47" @default.
- W2114748064 isParatext "false" @default.
- W2114748064 isRetracted "false" @default.
- W2114748064 magId "2114748064" @default.
- W2114748064 workType "article" @default.